ChemoCentryx (CCXI) Reports CCX168 Granted Ophan Drug Designation by U.S. FDA
Tweet Send to a Friend
ChemoCentryx (NASDAQ: CCXI) reported today that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for CCX168, an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
